Valneva SE
Specialty vaccine company developing and commercializing vaccines for infectious diseases.
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Manufacturing
Description
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-03-30 07:00 |
Valneva fera une présentation sur son candidat vaccin contre le chikungunya et …
|
French | 160.2 KB | ||
| 2023-03-30 07:00 |
Valneva to Present on its Chikungunya Vaccine Candidate and Host a Roundtable a…
|
English | 119.6 KB | ||
| 2023-03-23 07:00 |
Valneva Reports Full Year 2022 Results and Provides Corporate Updates
|
English | 390.5 KB | ||
| 2023-03-23 07:00 |
Valneva publie ses résultats financiers 2022 et fait un point sur ses activités
|
French | 1.3 MB | ||
| 2023-03-06 08:00 |
VALNEVA - Déclaration d’actions et de droits de vote : 28 février 2023
|
French | 14.0 KB | ||
| 2023-03-06 08:00 |
VALNEVA - Declaration of shares and voting rights - February 28, 2023
|
English | 14.3 KB | ||
| 2023-03-02 07:00 |
Valneva fournit des informations cliniques et règlementaires concernant son vac…
|
French | 163.4 KB | ||
| 2023-03-02 07:00 |
Valneva Provides Clinical and Regulatory Updates for its COVID-19 Vaccine VLA20…
|
English | 120.1 KB | ||
| 2023-03-01 17:45 |
Valneva fera une présentation à la 43e Cowen Annual Healthcare Conference
|
French | 104.1 KB | ||
| 2023-03-01 17:45 |
Valneva to Present at the Cowen 43rd Annual Healthcare Conference
|
English | 103.6 KB | ||
| 2023-02-20 07:00 |
La FDA accorde une revue prioritaire au dossier de demande d’autorisation du ca…
|
French | 196.0 KB | ||
| 2023-02-20 07:00 |
FDA Accepts Valneva’s Chikungunya Vaccine License Application for Priority Revi…
|
English | 152.8 KB | ||
| 2023-02-17 07:00 |
Pfizer et Valneva fournissent des informations actualisées sur l’essai de Phase…
|
French | 184.7 KB | ||
| 2023-02-17 07:00 |
Pfizer and Valneva Issue Update on Phase 3 Clinical Trial Evaluating Lyme Disea…
|
English | 178.6 KB | ||
| 2023-02-16 07:00 |
Valneva publie son chiffre d’affaires et sa trésorerie pour l’exercice 2022 et …
|
French | 216.9 KB |
Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valneva SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valneva SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
